Innovative Healthcare Advancements: Harnessing Artificial and Human Intelligence for Bionic Solutions
Rattachement africain : in. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
According to initial data, individuals who have been diagnosed with type 2 diabetes (T2DM) appear to be at a more chances of evolving breast cancer compared to those who have not received a T2DM diagnosis. The primary goal of the research was to estimate the efficacy of three dissimilar methods in forecasting the probability of breast cancer in T2DM patients with diverse attributes. To achieve this objective, a danger expectation model was created for breast cancer in individuals with T2DM using the primary data.To ensure a comprehensive analysis, we also gathered information on potential factors that may predict the growth of breast cancer. As the population sample size was restricted, we utilized Synthetic Minority Oversampling Technology to amplify the quantity of accessible data. Random assignment of data points to training or test sets was conducted at a ratio of roughly 39 to 1. Three distinct models, specifically Artificial Neural Network (ANN), Logistic Regression (LR), and Random Forest (RF), were assessed for effectiveness using a range of performance criteria, including as $F 1$ score, area under the receiver operation characteristic curves, recalled, and correctness. (AUC). AUC values for these models were as follows: LR had an AUC of 0.834, ANN had an AUC of 0.865, and RF had an AUC of 0.959, with RF having the greatest AUC. According to our study, the Random Forest model outperformed the LR and ANN models in correctly estimating the incidence of breast cancer in people with T2DM.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Innovative Healthcare Advancements: Harnessing Artificial and Human Intelligence for Bionic Solutions
- Date Crossref
- 05/06/2024
- Éditeur
- IEEE
- Type
- proceedings-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.